Headlands Technologies’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $444K | Buy |
8,329
+8,208
| +6,783% | +$438K | 0.05% | 328 |
|
|
2025
Q1 | $4.9K | Sell |
121
-1,914
| -94% | -$77.5K | ﹤0.01% | 1001 |
|
|
2024
Q4 | $56.6K | Sell |
2,035
-4,631
| -69% | -$129K | 0.01% | 792 |
|
|
2024
Q3 | $191K | Sell |
6,666
-10,337
| -61% | -$297K | 0.02% | 537 |
|
|
2024
Q2 | $399K | Buy |
17,003
+12,786
| +303% | +$300K | 0.04% | 321 |
|
|
2024
Q1 | $107K | Buy |
4,217
+3,024
| +253% | +$76.4K | 0.03% | 524 |
|
|
2023
Q4 | $27.9K | Buy |
+1,193
| New | +$27.9K | 0.01% | 620 |
|